{ "kind": "all", "value": "all", "collectionKey": "slides:all:all:all-document-kinds:all-producers:all-orientations", "filters": { "documentKinds": [], "sourceTypes": [], "orientations": [] }, "total": 319975, "page": 2702, "pageSize": 60, "pageCount": 5333, "rows": [ { "docId": "019de071-1a2d-7463-9f86-fbccbddc0002", "docSlug": "f70f60b02968bd8b01248415b8a77841", "documentTitle": "Aston Martin Lagonda | Results Presentation Deck | 28 slides", "authorId": "aston-martin-lagonda", "authorName": "Aston Martin Lagonda", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2021-06-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 9, "slideType": "revenue_buildup", "function": "analyze_data", "notes": "The chart illustrates the decline in revenue across four key segments: Sale of vehicles, Sale of parts, Servicing of vehicles, and Brand and motorsport.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de071-1a2d-7463-9f86-fbccbddc0002/9", "deckHref": "/decks/019de071-1a2d-7463-9f86-fbccbddc0002", "deckAnchorHref": "/decks/019de071-1a2d-7463-9f86-fbccbddc0002#slide-9", "loopMatches": [], "arcBeatMatches": [ { "to": 10, "from": 6, "beatId": "67fdd47b-b9f8-4b03-8558-73d9fa36ea3e", "arcName": "The Transformation Tale", "arcSlug": "transformation-tale", "beatName": "The Bridge", "beatSlug": "transformation-tale-the-bridge", "evidence": "The presentation deck outlines the bridge to transformation, including improved financial performance and a growth strategy.", "position": 1, "confidence": 0.8, "parentBeatName": "Resolution", "parentBeatSlug": "resolution" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de071-1a2d-7463-9f86-fbccbddc0002", "docSlug": "f70f60b02968bd8b01248415b8a77841", "documentTitle": "Aston Martin Lagonda | Results Presentation Deck | 28 slides", "authorId": "aston-martin-lagonda", "authorName": "Aston Martin Lagonda", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2021-06-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 10, "slideType": "before_after", "function": "analyze_data", "notes": "The slide uses a waterfall chart to bridge financial performance between two years, highlighting specific operational and market impacts.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de071-1a2d-7463-9f86-fbccbddc0002/10", "deckHref": "/decks/019de071-1a2d-7463-9f86-fbccbddc0002", "deckAnchorHref": "/decks/019de071-1a2d-7463-9f86-fbccbddc0002#slide-10", "loopMatches": [ { "to": 11, "from": 10, "name": "Before After", "slug": "21-before-after", "bestFor": "Product demos, process improvements, ROI justification", "matchId": "5cd8063d-f42c-4efa-a6c4-fd8d3e452843", "evidence": "The presentation deck shows a before-and-after comparison of the company's financial situation.", "position": 0, "objective": "To show the impact of refinancing on financial resilience", "structure": "The Old Way (Pain) -> The Moment of Change -> The New Way (Glory) -> The Measurable Delta", "confidence": 0.8, "description": "Show the dramatic contrast between the old way and the new way through side-by-side comparison" } ], "arcBeatMatches": [ { "to": 10, "from": 6, "beatId": "67fdd47b-b9f8-4b03-8558-73d9fa36ea3e", "arcName": "The Transformation Tale", "arcSlug": "transformation-tale", "beatName": "The Bridge", "beatSlug": "transformation-tale-the-bridge", "evidence": "The presentation deck outlines the bridge to transformation, including improved financial performance and a growth strategy.", "position": 1, "confidence": 0.8, "parentBeatName": "Resolution", "parentBeatSlug": "resolution" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de071-1a2d-7463-9f86-fbccbddc0002", "docSlug": "f70f60b02968bd8b01248415b8a77841", "documentTitle": "Aston Martin Lagonda | Results Presentation Deck | 28 slides", "authorId": "aston-martin-lagonda", "authorName": "Aston Martin Lagonda", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2021-06-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 11, "slideType": "revenue_buildup", "function": "analyze_data", "notes": "The chart uses a standard waterfall bridge format to reconcile PBT to Free Cash Flow.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de071-1a2d-7463-9f86-fbccbddc0002/11", "deckHref": "/decks/019de071-1a2d-7463-9f86-fbccbddc0002", "deckAnchorHref": "/decks/019de071-1a2d-7463-9f86-fbccbddc0002#slide-11", "loopMatches": [ { "to": 11, "from": 10, "name": "Before After", "slug": "21-before-after", "bestFor": "Product demos, process improvements, ROI justification", "matchId": "5cd8063d-f42c-4efa-a6c4-fd8d3e452843", "evidence": "The presentation deck shows a before-and-after comparison of the company's financial situation.", "position": 0, "objective": "To show the impact of refinancing on financial resilience", "structure": "The Old Way (Pain) -> The Moment of Change -> The New Way (Glory) -> The Measurable Delta", "confidence": 0.8, "description": "Show the dramatic contrast between the old way and the new way through side-by-side comparison" } ], "arcBeatMatches": [ { "to": 15, "from": 11, "beatId": "d181fb30-2313-406e-b459-e8effbbe399a", "arcName": "The Transformation Tale", "arcSlug": "transformation-tale", "beatName": "Future Vision (Gain)", "beatSlug": "transformation-tale-future-vision-gain", "evidence": "The presentation deck outlines the future vision, including a growth strategy and operational excellence.", "position": 2, "confidence": 0.8, "parentBeatName": "Turn", "parentBeatSlug": "turn" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de071-1a2d-7463-9f86-fbccbddc0002", "docSlug": "f70f60b02968bd8b01248415b8a77841", "documentTitle": "Aston Martin Lagonda | Results Presentation Deck | 28 slides", "authorId": "aston-martin-lagonda", "authorName": "Aston Martin Lagonda", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2021-06-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 12, "slideType": "before_after", "function": "analyze_data", "notes": "The slide uses two waterfall charts to bridge the opening and closing balances for cash and net debt.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de071-1a2d-7463-9f86-fbccbddc0002/12", "deckHref": "/decks/019de071-1a2d-7463-9f86-fbccbddc0002", "deckAnchorHref": "/decks/019de071-1a2d-7463-9f86-fbccbddc0002#slide-12", "loopMatches": [], "arcBeatMatches": [ { "to": 15, "from": 11, "beatId": "d181fb30-2313-406e-b459-e8effbbe399a", "arcName": "The Transformation Tale", "arcSlug": "transformation-tale", "beatName": "Future Vision (Gain)", "beatSlug": "transformation-tale-future-vision-gain", "evidence": "The presentation deck outlines the future vision, including a growth strategy and operational excellence.", "position": 2, "confidence": 0.8, "parentBeatName": "Turn", "parentBeatSlug": "turn" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de071-1a2d-7463-9f86-fbccbddc0002", "docSlug": "f70f60b02968bd8b01248415b8a77841", "documentTitle": "Aston Martin Lagonda | Results Presentation Deck | 28 slides", "authorId": "aston-martin-lagonda", "authorName": "Aston Martin Lagonda", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2021-06-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 13, "slideType": "kpi_overview", "function": "summarize", "notes": "Includes specific financial metrics for wholesales, margins, and expenses.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de071-1a2d-7463-9f86-fbccbddc0002/13", "deckHref": "/decks/019de071-1a2d-7463-9f86-fbccbddc0002", "deckAnchorHref": "/decks/019de071-1a2d-7463-9f86-fbccbddc0002#slide-13", "loopMatches": [], "arcBeatMatches": [ { "to": 15, "from": 11, "beatId": "d181fb30-2313-406e-b459-e8effbbe399a", "arcName": "The Transformation Tale", "arcSlug": "transformation-tale", "beatName": "Future Vision (Gain)", "beatSlug": "transformation-tale-future-vision-gain", "evidence": "The presentation deck outlines the future vision, including a growth strategy and operational excellence.", "position": 2, "confidence": 0.8, "parentBeatName": "Turn", "parentBeatSlug": "turn" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de071-1a2d-7463-9f86-fbccbddc0002", "docSlug": "f70f60b02968bd8b01248415b8a77841", "documentTitle": "Aston Martin Lagonda | Results Presentation Deck | 28 slides", "authorId": "aston-martin-lagonda", "authorName": "Aston Martin Lagonda", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2021-06-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 14, "slideType": "cover", "function": "front_matter", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de071-1a2d-7463-9f86-fbccbddc0002/14", "deckHref": "/decks/019de071-1a2d-7463-9f86-fbccbddc0002", "deckAnchorHref": "/decks/019de071-1a2d-7463-9f86-fbccbddc0002#slide-14", "loopMatches": [], "arcBeatMatches": [ { "to": 15, "from": 11, "beatId": "d181fb30-2313-406e-b459-e8effbbe399a", "arcName": "The Transformation Tale", "arcSlug": "transformation-tale", "beatName": "Future Vision (Gain)", "beatSlug": "transformation-tale-future-vision-gain", "evidence": "The presentation deck outlines the future vision, including a growth strategy and operational excellence.", "position": 2, "confidence": 0.8, "parentBeatName": "Turn", "parentBeatSlug": "turn" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de071-1a2d-7463-9f86-fbccbddc0002", "docSlug": "f70f60b02968bd8b01248415b8a77841", "documentTitle": "Aston Martin Lagonda | Results Presentation Deck | 28 slides", "authorId": "aston-martin-lagonda", "authorName": "Aston Martin Lagonda", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2021-06-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 15, "slideType": "key_takeaways", "function": "summarize", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de071-1a2d-7463-9f86-fbccbddc0002/15", "deckHref": "/decks/019de071-1a2d-7463-9f86-fbccbddc0002", "deckAnchorHref": "/decks/019de071-1a2d-7463-9f86-fbccbddc0002#slide-15", "loopMatches": [ { "to": 16, "from": 15, "name": "Quick Win Big Bet", "slug": "47-quick-win-big-bet", "bestFor": "Transformation planning, 100-day plans, resource allocation", "matchId": "d50ad7d8-7552-4a3c-b5d0-cb557c0fe272", "evidence": "The presentation deck outlines the company's growth strategy and highlights quick wins and big bets.", "position": 1, "objective": "To highlight the company's growth strategy", "structure": "The Full List -> Quick Wins (Low effort, High impact) -> Big Bets (High effort, High impact) -> Sequenced Roadmap", "confidence": 0.7, "description": "Separate initiatives into immediate wins and longer-term strategic bets" } ], "arcBeatMatches": [ { "to": 15, "from": 11, "beatId": "d181fb30-2313-406e-b459-e8effbbe399a", "arcName": "The Transformation Tale", "arcSlug": "transformation-tale", "beatName": "Future Vision (Gain)", "beatSlug": "transformation-tale-future-vision-gain", "evidence": "The presentation deck outlines the future vision, including a growth strategy and operational excellence.", "position": 2, "confidence": 0.8, "parentBeatName": "Turn", "parentBeatSlug": "turn" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de071-1a2d-7463-9f86-fbccbddc0002", "docSlug": "f70f60b02968bd8b01248415b8a77841", "documentTitle": "Aston Martin Lagonda | Results Presentation Deck | 28 slides", "authorId": "aston-martin-lagonda", "authorName": "Aston Martin Lagonda", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2021-06-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 16, "slideType": "key_takeaways", "function": "summarize", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de071-1a2d-7463-9f86-fbccbddc0002/16", "deckHref": "/decks/019de071-1a2d-7463-9f86-fbccbddc0002", "deckAnchorHref": "/decks/019de071-1a2d-7463-9f86-fbccbddc0002#slide-16", "loopMatches": [ { "to": 16, "from": 15, "name": "Quick Win Big Bet", "slug": "47-quick-win-big-bet", "bestFor": "Transformation planning, 100-day plans, resource allocation", "matchId": "d50ad7d8-7552-4a3c-b5d0-cb557c0fe272", "evidence": "The presentation deck outlines the company's growth strategy and highlights quick wins and big bets.", "position": 1, "objective": "To highlight the company's growth strategy", "structure": "The Full List -> Quick Wins (Low effort, High impact) -> Big Bets (High effort, High impact) -> Sequenced Roadmap", "confidence": 0.7, "description": "Separate initiatives into immediate wins and longer-term strategic bets" } ], "arcBeatMatches": [ { "to": 20, "from": 16, "beatId": "ab0c2e8f-61e3-489f-8252-66673d989964", "arcName": "The Transformation Tale", "arcSlug": "transformation-tale", "beatName": "Action", "beatSlug": "aida-action", "evidence": "The presentation deck outlines the action plan, including Project Horizon and a growth strategy.", "position": 3, "confidence": 0.8, "parentBeatName": "Resolution", "parentBeatSlug": "resolution" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de071-1a2d-7463-9f86-fbccbddc0002", "docSlug": "f70f60b02968bd8b01248415b8a77841", "documentTitle": "Aston Martin Lagonda | Results Presentation Deck | 28 slides", "authorId": "aston-martin-lagonda", "authorName": "Aston Martin Lagonda", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2021-06-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 17, "slideType": "roadmap", "function": "plan_implementation", "notes": "The slide outlines a transition from current models to future electrified/BEV models using Mercedes-Benz technology.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de071-1a2d-7463-9f86-fbccbddc0002/17", "deckHref": "/decks/019de071-1a2d-7463-9f86-fbccbddc0002", "deckAnchorHref": "/decks/019de071-1a2d-7463-9f86-fbccbddc0002#slide-17", "loopMatches": [], "arcBeatMatches": [ { "to": 20, "from": 16, "beatId": "ab0c2e8f-61e3-489f-8252-66673d989964", "arcName": "The Transformation Tale", "arcSlug": "transformation-tale", "beatName": "Action", "beatSlug": "aida-action", "evidence": "The presentation deck outlines the action plan, including Project Horizon and a growth strategy.", "position": 3, "confidence": 0.8, "parentBeatName": "Resolution", "parentBeatSlug": "resolution" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de071-1a2d-7463-9f86-fbccbddc0002", "docSlug": "f70f60b02968bd8b01248415b8a77841", "documentTitle": "Aston Martin Lagonda | Results Presentation Deck | 28 slides", "authorId": "aston-martin-lagonda", "authorName": "Aston Martin Lagonda", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2021-06-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 18, "slideType": "key_messages", "function": "summarize", "notes": "The slide uses a dark, high-contrast aesthetic typical of luxury automotive branding.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de071-1a2d-7463-9f86-fbccbddc0002/18", "deckHref": "/decks/019de071-1a2d-7463-9f86-fbccbddc0002", "deckAnchorHref": "/decks/019de071-1a2d-7463-9f86-fbccbddc0002#slide-18", "loopMatches": [], "arcBeatMatches": [ { "to": 20, "from": 16, "beatId": "ab0c2e8f-61e3-489f-8252-66673d989964", "arcName": "The Transformation Tale", "arcSlug": "transformation-tale", "beatName": "Action", "beatSlug": "aida-action", "evidence": "The presentation deck outlines the action plan, including Project Horizon and a growth strategy.", "position": 3, "confidence": 0.8, "parentBeatName": "Resolution", "parentBeatSlug": "resolution" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de071-1a2d-7463-9f86-fbccbddc0002", "docSlug": "f70f60b02968bd8b01248415b8a77841", "documentTitle": "Aston Martin Lagonda | Results Presentation Deck | 28 slides", "authorId": "aston-martin-lagonda", "authorName": "Aston Martin Lagonda", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2021-06-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 19, "slideType": "key_messages", "function": "summarize", "notes": "The slide uses a split-screen layout with text on the left and a hero image of an Aston Martin DBX on the right.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de071-1a2d-7463-9f86-fbccbddc0002/19", "deckHref": "/decks/019de071-1a2d-7463-9f86-fbccbddc0002", "deckAnchorHref": "/decks/019de071-1a2d-7463-9f86-fbccbddc0002#slide-19", "loopMatches": [], "arcBeatMatches": [ { "to": 20, "from": 16, "beatId": "ab0c2e8f-61e3-489f-8252-66673d989964", "arcName": "The Transformation Tale", "arcSlug": "transformation-tale", "beatName": "Action", "beatSlug": "aida-action", "evidence": "The presentation deck outlines the action plan, including Project Horizon and a growth strategy.", "position": 3, "confidence": 0.8, "parentBeatName": "Resolution", "parentBeatSlug": "resolution" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de071-1a2d-7463-9f86-fbccbddc0002", "docSlug": "f70f60b02968bd8b01248415b8a77841", "documentTitle": "Aston Martin Lagonda | Results Presentation Deck | 28 slides", "authorId": "aston-martin-lagonda", "authorName": "Aston Martin Lagonda", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2021-06-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 20, "slideType": "closing_ask", "function": "transition", "notes": "The slide serves as a visual placeholder for the Q&A portion of the presentation.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de071-1a2d-7463-9f86-fbccbddc0002/20", "deckHref": "/decks/019de071-1a2d-7463-9f86-fbccbddc0002", "deckAnchorHref": "/decks/019de071-1a2d-7463-9f86-fbccbddc0002#slide-20", "loopMatches": [], "arcBeatMatches": [ { "to": 20, "from": 16, "beatId": "ab0c2e8f-61e3-489f-8252-66673d989964", "arcName": "The Transformation Tale", "arcSlug": "transformation-tale", "beatName": "Action", "beatSlug": "aida-action", "evidence": "The presentation deck outlines the action plan, including Project Horizon and a growth strategy.", "position": 3, "confidence": 0.8, "parentBeatName": "Resolution", "parentBeatSlug": "resolution" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de071-1a2d-7463-9f86-fbccbddc0002", "docSlug": "f70f60b02968bd8b01248415b8a77841", "documentTitle": "Aston Martin Lagonda | Results Presentation Deck | 28 slides", "authorId": "aston-martin-lagonda", "authorName": "Aston Martin Lagonda", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2021-06-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 21, "slideType": "kpi_overview", "function": "analyze_data", "notes": "Includes footnotes regarding model definitions and data restatements.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de071-1a2d-7463-9f86-fbccbddc0002/21", "deckHref": "/decks/019de071-1a2d-7463-9f86-fbccbddc0002", "deckAnchorHref": "/decks/019de071-1a2d-7463-9f86-fbccbddc0002#slide-21", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de071-1a2d-7463-9f86-fbccbddc0002", "docSlug": "f70f60b02968bd8b01248415b8a77841", "documentTitle": "Aston Martin Lagonda | Results Presentation Deck | 28 slides", "authorId": "aston-martin-lagonda", "authorName": "Aston Martin Lagonda", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2021-06-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 22, "slideType": "appendix_data", "function": "analyze_data", "notes": "Includes footnotes regarding APMs, restatements, and specific exclusions.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de071-1a2d-7463-9f86-fbccbddc0002/22", "deckHref": "/decks/019de071-1a2d-7463-9f86-fbccbddc0002", "deckAnchorHref": "/decks/019de071-1a2d-7463-9f86-fbccbddc0002#slide-22", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de071-1a2d-7463-9f86-fbccbddc0002", "docSlug": "f70f60b02968bd8b01248415b8a77841", "documentTitle": "Aston Martin Lagonda | Results Presentation Deck | 28 slides", "authorId": "aston-martin-lagonda", "authorName": "Aston Martin Lagonda", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2021-06-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 23, "slideType": "appendix_data", "function": "analyze_data", "notes": "The slide provides a detailed breakdown of Alternative Performance Measures (APMs) for Aston Martin Lagonda.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de071-1a2d-7463-9f86-fbccbddc0002/23", "deckHref": "/decks/019de071-1a2d-7463-9f86-fbccbddc0002", "deckAnchorHref": "/decks/019de071-1a2d-7463-9f86-fbccbddc0002#slide-23", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de071-1a2d-7463-9f86-fbccbddc0002", "docSlug": "f70f60b02968bd8b01248415b8a77841", "documentTitle": "Aston Martin Lagonda | Results Presentation Deck | 28 slides", "authorId": "aston-martin-lagonda", "authorName": "Aston Martin Lagonda", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2021-06-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 24, "slideType": "appendix_data", "function": "analyze_data", "notes": "Slide 24 of a presentation by Aston Martin Lagonda.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de071-1a2d-7463-9f86-fbccbddc0002/24", "deckHref": "/decks/019de071-1a2d-7463-9f86-fbccbddc0002", "deckAnchorHref": "/decks/019de071-1a2d-7463-9f86-fbccbddc0002#slide-24", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de071-1a2d-7463-9f86-fbccbddc0002", "docSlug": "f70f60b02968bd8b01248415b8a77841", "documentTitle": "Aston Martin Lagonda | Results Presentation Deck | 28 slides", "authorId": "aston-martin-lagonda", "authorName": "Aston Martin Lagonda", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2021-06-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 25, "slideType": "kpi_overview", "function": "analyze_data", "notes": "Includes wholesale volumes, revenue, EBITDA, operating profit/loss, and loss before tax.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de071-1a2d-7463-9f86-fbccbddc0002/25", "deckHref": "/decks/019de071-1a2d-7463-9f86-fbccbddc0002", "deckAnchorHref": "/decks/019de071-1a2d-7463-9f86-fbccbddc0002#slide-25", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de071-1a2d-7463-9f86-fbccbddc0002", "docSlug": "f70f60b02968bd8b01248415b8a77841", "documentTitle": "Aston Martin Lagonda | Results Presentation Deck | 28 slides", "authorId": "aston-martin-lagonda", "authorName": "Aston Martin Lagonda", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2021-06-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 26, "slideType": "appendix_disclosure", "function": "other", "notes": "This is a standard financial disclosure slide defining non-GAAP metrics.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de071-1a2d-7463-9f86-fbccbddc0002/26", "deckHref": "/decks/019de071-1a2d-7463-9f86-fbccbddc0002", "deckAnchorHref": "/decks/019de071-1a2d-7463-9f86-fbccbddc0002#slide-26", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de071-1a2d-7463-9f86-fbccbddc0002", "docSlug": "f70f60b02968bd8b01248415b8a77841", "documentTitle": "Aston Martin Lagonda | Results Presentation Deck | 28 slides", "authorId": "aston-martin-lagonda", "authorName": "Aston Martin Lagonda", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2021-06-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 27, "slideType": "disclaimer", "function": "other", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de071-1a2d-7463-9f86-fbccbddc0002/27", "deckHref": "/decks/019de071-1a2d-7463-9f86-fbccbddc0002", "deckAnchorHref": "/decks/019de071-1a2d-7463-9f86-fbccbddc0002#slide-27", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de071-1a2d-7463-9f86-fbccbddc0002", "docSlug": "f70f60b02968bd8b01248415b8a77841", "documentTitle": "Aston Martin Lagonda | Results Presentation Deck | 28 slides", "authorId": "aston-martin-lagonda", "authorName": "Aston Martin Lagonda", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2021-06-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 28, "slideType": "appendix", "function": "other", "notes": "Closing slide with contact details.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de071-1a2d-7463-9f86-fbccbddc0002/28", "deckHref": "/decks/019de071-1a2d-7463-9f86-fbccbddc0002", "deckAnchorHref": "/decks/019de071-1a2d-7463-9f86-fbccbddc0002#slide-28", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de071-1b25-714a-a556-99258540557d", "docSlug": "126b67b2e7b5b97a9224e2ecbdcc54df", "documentTitle": "Aston Martin | Results Presentation Deck | 12 slides", "authorId": "aston-martin", "authorName": "Aston Martin Lagonda", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2021-06-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 1, "slideType": "cover", "function": "front_matter", "notes": "Features Aston Martin F1 safety and medical cars on a track.", "imagePath": "https://imgproxy.kitesheet.com/LA5-W1PMdKj3y157K6wqrrChkcSLihJSf-YMkfxtQPM/rs:fit:1200:1200:0/q:82/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy8xMjZiNjdiMmU3YjViOTdhOTIyNGUyZWNiZGNjNTRkZi9wMDAxLmpwZw", "matchCount": 1, "evidence": null, "slideHref": "/slides/019de071-1b25-714a-a556-99258540557d/1", "deckHref": "/decks/019de071-1b25-714a-a556-99258540557d", "deckAnchorHref": "/decks/019de071-1b25-714a-a556-99258540557d#slide-1", "loopMatches": [], "arcBeatMatches": [ { "to": 2, "from": 1, "beatId": "7adece10-b3c1-415e-acf9-0e8048d5ecfb", "arcName": "Monroe's Motivated Sequence", "arcSlug": "monroes-sequence", "beatName": "Attention", "beatSlug": "monroes-sequence-attention", "evidence": "The cover slide and key takeaways aim to grab the audience's attention.", "position": 0, "confidence": 0.8, "parentBeatName": "Hook", "parentBeatSlug": "hook" } ], "imagePathAlt": "https://imgproxy.kitesheet.com/pPKc2QZ9kn6viWMq_BQd9iLXrDUFdSDWHuG6V1g2_1k/rs:fit:1200:1200:0/q:82/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy8xMjZiNjdiMmU3YjViOTdhOTIyNGUyZWNiZGNjNTRkZi9wMDAxLnBuZw", "thumbSrc": "https://imgproxy.kitesheet.com/_aGSqo70aKTPEae4iWkXO3gniB1_sDHSL-M4ZmdAXxo/rs:fit:480:480:0/q:78/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy8xMjZiNjdiMmU3YjViOTdhOTIyNGUyZWNiZGNjNTRkZi9wMDAxLmpwZw", "thumbSrcAlt": "https://imgproxy.kitesheet.com/oXqQLETsh3cxWGBmqVP2huppFGiUAUbviW6dmvgpAvg/rs:fit:480:480:0/q:78/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy8xMjZiNjdiMmU3YjViOTdhOTIyNGUyZWNiZGNjNTRkZi9wMDAxLnBuZw" }, { "docId": "019de071-1b25-714a-a556-99258540557d", "docSlug": "126b67b2e7b5b97a9224e2ecbdcc54df", "documentTitle": "Aston Martin | Results Presentation Deck | 12 slides", "authorId": "aston-martin", "authorName": "Aston Martin Lagonda", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2021-06-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 2, "slideType": "key_takeaways", "function": "summarize", "notes": "The slide uses a numbered list format to present progress on 'Project Horizon'.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de071-1b25-714a-a556-99258540557d/2", "deckHref": "/decks/019de071-1b25-714a-a556-99258540557d", "deckAnchorHref": "/decks/019de071-1b25-714a-a556-99258540557d#slide-2", "loopMatches": [], "arcBeatMatches": [ { "to": 2, "from": 1, "beatId": "7adece10-b3c1-415e-acf9-0e8048d5ecfb", "arcName": "Monroe's Motivated Sequence", "arcSlug": "monroes-sequence", "beatName": "Attention", "beatSlug": "monroes-sequence-attention", "evidence": "The cover slide and key takeaways aim to grab the audience's attention.", "position": 0, "confidence": 0.8, "parentBeatName": "Hook", "parentBeatSlug": "hook" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de071-1b25-714a-a556-99258540557d", "docSlug": "126b67b2e7b5b97a9224e2ecbdcc54df", "documentTitle": "Aston Martin | Results Presentation Deck | 12 slides", "authorId": "aston-martin", "authorName": "Aston Martin Lagonda", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2021-06-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 3, "slideType": "kpi_overview", "function": "analyze_data", "notes": "The slide uses a bar chart comparison for six metrics: Total Wholesales, Adjusted Operating Loss, Revenues, Free Cash Flow, Adjusted EBITDA, and Net Debt.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de071-1b25-714a-a556-99258540557d/3", "deckHref": "/decks/019de071-1b25-714a-a556-99258540557d", "deckAnchorHref": "/decks/019de071-1b25-714a-a556-99258540557d#slide-3", "loopMatches": [ { "to": 7, "from": 3, "name": "Cost Of Inaction", "slug": "27-cost-of-inaction", "bestFor": "Urgent budget requests, compliance, risk mitigation", "matchId": "29dadc0b-ec67-45e2-a70e-2ae7d7d94c34", "evidence": "The document implies that not taking action would result in continued poor performance.", "position": 0, "objective": "What are the consequences of not taking action to improve performance?", "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point", "confidence": 0.6, "description": "Quantify what happens if the audience does nothing" } ], "arcBeatMatches": [ { "to": 5, "from": 3, "beatId": "be5c28a6-7d2f-4b8d-8094-a579b93cd233", "arcName": "Monroe's Motivated Sequence", "arcSlug": "monroes-sequence", "beatName": "Need", "beatSlug": "monroes-sequence-need", "evidence": "The KPI overview slides highlight the company's performance and potential areas for improvement.", "position": 1, "confidence": 0.8, "parentBeatName": "Complication", "parentBeatSlug": "complication" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de071-1b25-714a-a556-99258540557d", "docSlug": "126b67b2e7b5b97a9224e2ecbdcc54df", "documentTitle": "Aston Martin | Results Presentation Deck | 12 slides", "authorId": "aston-martin", "authorName": "Aston Martin Lagonda", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2021-06-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 4, "slideType": "kpi_overview", "function": "analyze_data", "notes": "Includes a donut chart for model mix, a map for regional growth percentages, and bar charts for regional volume and ASP.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de071-1b25-714a-a556-99258540557d/4", "deckHref": "/decks/019de071-1b25-714a-a556-99258540557d", "deckAnchorHref": "/decks/019de071-1b25-714a-a556-99258540557d#slide-4", "loopMatches": [ { "to": 7, "from": 3, "name": "Cost Of Inaction", "slug": "27-cost-of-inaction", "bestFor": "Urgent budget requests, compliance, risk mitigation", "matchId": "29dadc0b-ec67-45e2-a70e-2ae7d7d94c34", "evidence": "The document implies that not taking action would result in continued poor performance.", "position": 0, "objective": "What are the consequences of not taking action to improve performance?", "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point", "confidence": 0.6, "description": "Quantify what happens if the audience does nothing" } ], "arcBeatMatches": [ { "to": 5, "from": 3, "beatId": "be5c28a6-7d2f-4b8d-8094-a579b93cd233", "arcName": "Monroe's Motivated Sequence", "arcSlug": "monroes-sequence", "beatName": "Need", "beatSlug": "monroes-sequence-need", "evidence": "The KPI overview slides highlight the company's performance and potential areas for improvement.", "position": 1, "confidence": 0.8, "parentBeatName": "Complication", "parentBeatSlug": "complication" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de071-1b25-714a-a556-99258540557d", "docSlug": "126b67b2e7b5b97a9224e2ecbdcc54df", "documentTitle": "Aston Martin | Results Presentation Deck | 12 slides", "authorId": "aston-martin", "authorName": "Aston Martin Lagonda", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2021-06-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 5, "slideType": "kpi_overview", "function": "analyze_data", "notes": "The slide uses a waterfall bridge to explain the variance in Adjusted EBITDA between two periods.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de071-1b25-714a-a556-99258540557d/5", "deckHref": "/decks/019de071-1b25-714a-a556-99258540557d", "deckAnchorHref": "/decks/019de071-1b25-714a-a556-99258540557d#slide-5", "loopMatches": [ { "to": 7, "from": 3, "name": "Cost Of Inaction", "slug": "27-cost-of-inaction", "bestFor": "Urgent budget requests, compliance, risk mitigation", "matchId": "29dadc0b-ec67-45e2-a70e-2ae7d7d94c34", "evidence": "The document implies that not taking action would result in continued poor performance.", "position": 0, "objective": "What are the consequences of not taking action to improve performance?", "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point", "confidence": 0.6, "description": "Quantify what happens if the audience does nothing" } ], "arcBeatMatches": [ { "to": 5, "from": 3, "beatId": "be5c28a6-7d2f-4b8d-8094-a579b93cd233", "arcName": "Monroe's Motivated Sequence", "arcSlug": "monroes-sequence", "beatName": "Need", "beatSlug": "monroes-sequence-need", "evidence": "The KPI overview slides highlight the company's performance and potential areas for improvement.", "position": 1, "confidence": 0.8, "parentBeatName": "Complication", "parentBeatSlug": "complication" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de071-1b25-714a-a556-99258540557d", "docSlug": "126b67b2e7b5b97a9224e2ecbdcc54df", "documentTitle": "Aston Martin | Results Presentation Deck | 12 slides", "authorId": "aston-martin", "authorName": "Aston Martin Lagonda", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2021-06-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 6, "slideType": "valuation_reveal", "function": "show_valuation_bridge", "notes": "The slide uses two separate waterfall charts to bridge cash and net debt positions.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de071-1b25-714a-a556-99258540557d/6", "deckHref": "/decks/019de071-1b25-714a-a556-99258540557d", "deckAnchorHref": "/decks/019de071-1b25-714a-a556-99258540557d#slide-6", "loopMatches": [ { "to": 7, "from": 3, "name": "Cost Of Inaction", "slug": "27-cost-of-inaction", "bestFor": "Urgent budget requests, compliance, risk mitigation", "matchId": "29dadc0b-ec67-45e2-a70e-2ae7d7d94c34", "evidence": "The document implies that not taking action would result in continued poor performance.", "position": 0, "objective": "What are the consequences of not taking action to improve performance?", "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point", "confidence": 0.6, "description": "Quantify what happens if the audience does nothing" } ], "arcBeatMatches": [ { "to": 7, "from": 6, "beatId": "2fb9a5e1-688a-4ede-b4e7-48d42317e623", "arcName": "Monroe's Motivated Sequence", "arcSlug": "monroes-sequence", "beatName": "Satisfaction", "beatSlug": "monroes-sequence-satisfaction", "evidence": "The valuation reveal and outlook unchanged slides demonstrate the company's current situation and future prospects.", "position": 2, "confidence": 0.8, "parentBeatName": "Turn", "parentBeatSlug": "turn" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de071-1b25-714a-a556-99258540557d", "docSlug": "126b67b2e7b5b97a9224e2ecbdcc54df", "documentTitle": "Aston Martin | Results Presentation Deck | 12 slides", "authorId": "aston-martin", "authorName": "Aston Martin Lagonda", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2021-06-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 7, "slideType": "kpi_overview", "function": "summarize", "notes": "Includes specific financial metrics for Aston Martin Lagonda.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de071-1b25-714a-a556-99258540557d/7", "deckHref": "/decks/019de071-1b25-714a-a556-99258540557d", "deckAnchorHref": "/decks/019de071-1b25-714a-a556-99258540557d#slide-7", "loopMatches": [ { "to": 7, "from": 3, "name": "Cost Of Inaction", "slug": "27-cost-of-inaction", "bestFor": "Urgent budget requests, compliance, risk mitigation", "matchId": "29dadc0b-ec67-45e2-a70e-2ae7d7d94c34", "evidence": "The document implies that not taking action would result in continued poor performance.", "position": 0, "objective": "What are the consequences of not taking action to improve performance?", "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point", "confidence": 0.6, "description": "Quantify what happens if the audience does nothing" } ], "arcBeatMatches": [ { "to": 7, "from": 6, "beatId": "2fb9a5e1-688a-4ede-b4e7-48d42317e623", "arcName": "Monroe's Motivated Sequence", "arcSlug": "monroes-sequence", "beatName": "Satisfaction", "beatSlug": "monroes-sequence-satisfaction", "evidence": "The valuation reveal and outlook unchanged slides demonstrate the company's current situation and future prospects.", "position": 2, "confidence": 0.8, "parentBeatName": "Turn", "parentBeatSlug": "turn" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de071-1b25-714a-a556-99258540557d", "docSlug": "126b67b2e7b5b97a9224e2ecbdcc54df", "documentTitle": "Aston Martin | Results Presentation Deck | 12 slides", "authorId": "aston-martin", "authorName": "Aston Martin Lagonda", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2021-06-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 8, "slideType": "closing_ask", "function": "state_next_steps", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de071-1b25-714a-a556-99258540557d/8", "deckHref": "/decks/019de071-1b25-714a-a556-99258540557d", "deckAnchorHref": "/decks/019de071-1b25-714a-a556-99258540557d#slide-8", "loopMatches": [], "arcBeatMatches": [ { "to": 12, "from": 8, "beatId": "246dfd69-3974-477c-a25b-caeefbb567cd", "arcName": "Monroe's Motivated Sequence", "arcSlug": "monroes-sequence", "beatName": "Action", "beatSlug": "monroes-sequence-action", "evidence": "The Q&A session and appendix slides provide additional information and encourage discussion.", "position": 3, "confidence": 0.8, "parentBeatName": "Resolution", "parentBeatSlug": "resolution" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de071-1b25-714a-a556-99258540557d", "docSlug": "126b67b2e7b5b97a9224e2ecbdcc54df", "documentTitle": "Aston Martin | Results Presentation Deck | 12 slides", "authorId": "aston-martin", "authorName": "Aston Martin Lagonda", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2021-06-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 9, "slideType": "appendix_data", "function": "analyze_data", "notes": "The slide contains two side-by-side financial tables. The left table covers the Income Statement, and the right table covers Cash Flow and Net Debt.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de071-1b25-714a-a556-99258540557d/9", "deckHref": "/decks/019de071-1b25-714a-a556-99258540557d", "deckAnchorHref": "/decks/019de071-1b25-714a-a556-99258540557d#slide-9", "loopMatches": [], "arcBeatMatches": [ { "to": 12, "from": 8, "beatId": "246dfd69-3974-477c-a25b-caeefbb567cd", "arcName": "Monroe's Motivated Sequence", "arcSlug": "monroes-sequence", "beatName": "Action", "beatSlug": "monroes-sequence-action", "evidence": "The Q&A session and appendix slides provide additional information and encourage discussion.", "position": 3, "confidence": 0.8, "parentBeatName": "Resolution", "parentBeatSlug": "resolution" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de071-1b25-714a-a556-99258540557d", "docSlug": "126b67b2e7b5b97a9224e2ecbdcc54df", "documentTitle": "Aston Martin | Results Presentation Deck | 12 slides", "authorId": "aston-martin", "authorName": "Aston Martin Lagonda", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2021-06-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 10, "slideType": "appendix_methodology", "function": "other", "notes": "This slide provides the methodology/definitions for non-GAAP financial metrics used in the presentation.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de071-1b25-714a-a556-99258540557d/10", "deckHref": "/decks/019de071-1b25-714a-a556-99258540557d", "deckAnchorHref": "/decks/019de071-1b25-714a-a556-99258540557d#slide-10", "loopMatches": [], "arcBeatMatches": [ { "to": 12, "from": 8, "beatId": "246dfd69-3974-477c-a25b-caeefbb567cd", "arcName": "Monroe's Motivated Sequence", "arcSlug": "monroes-sequence", "beatName": "Action", "beatSlug": "monroes-sequence-action", "evidence": "The Q&A session and appendix slides provide additional information and encourage discussion.", "position": 3, "confidence": 0.8, "parentBeatName": "Resolution", "parentBeatSlug": "resolution" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de071-1b25-714a-a556-99258540557d", "docSlug": "126b67b2e7b5b97a9224e2ecbdcc54df", "documentTitle": "Aston Martin | Results Presentation Deck | 12 slides", "authorId": "aston-martin", "authorName": "Aston Martin Lagonda", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2021-06-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 11, "slideType": "disclaimer", "function": "other", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de071-1b25-714a-a556-99258540557d/11", "deckHref": "/decks/019de071-1b25-714a-a556-99258540557d", "deckAnchorHref": "/decks/019de071-1b25-714a-a556-99258540557d#slide-11", "loopMatches": [], "arcBeatMatches": [ { "to": 12, "from": 8, "beatId": "246dfd69-3974-477c-a25b-caeefbb567cd", "arcName": "Monroe's Motivated Sequence", "arcSlug": "monroes-sequence", "beatName": "Action", "beatSlug": "monroes-sequence-action", "evidence": "The Q&A session and appendix slides provide additional information and encourage discussion.", "position": 3, "confidence": 0.8, "parentBeatName": "Resolution", "parentBeatSlug": "resolution" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de071-1b25-714a-a556-99258540557d", "docSlug": "126b67b2e7b5b97a9224e2ecbdcc54df", "documentTitle": "Aston Martin | Results Presentation Deck | 12 slides", "authorId": "aston-martin", "authorName": "Aston Martin Lagonda", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2021-06-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 12, "slideType": "closing_ask", "function": "state_next_steps", "notes": "This is a standard closing slide for an investor presentation.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de071-1b25-714a-a556-99258540557d/12", "deckHref": "/decks/019de071-1b25-714a-a556-99258540557d", "deckAnchorHref": "/decks/019de071-1b25-714a-a556-99258540557d#slide-12", "loopMatches": [], "arcBeatMatches": [ { "to": 12, "from": 8, "beatId": "246dfd69-3974-477c-a25b-caeefbb567cd", "arcName": "Monroe's Motivated Sequence", "arcSlug": "monroes-sequence", "beatName": "Action", "beatSlug": "monroes-sequence-action", "evidence": "The Q&A session and appendix slides provide additional information and encourage discussion.", "position": 3, "confidence": 0.8, "parentBeatName": "Resolution", "parentBeatSlug": "resolution" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de071-1bdd-70bb-9c61-980d0c38b663", "docSlug": "a4792f18c57ea3f4ba27e696a63520de", "documentTitle": "AstraZeneca | Investor Day Presentation Deck | 40 slides", "authorId": "astrazeneca", "authorName": "AstraZeneca", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2021-06-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.4148858, "pageNumber": 1, "slideType": "cover", "function": "front_matter", "notes": null, "imagePath": "https://imgproxy.kitesheet.com/l6QcjaVTNY8sVvAHdXDKrLpqhBB9dFESe6s77BZsFjE/rs:fit:1200:1200:0/q:82/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy9hNDc5MmYxOGM1N2VhM2Y0YmEyN2U2OTZhNjM1MjBkZS9wMDAxLmpwZw", "matchCount": 1, "evidence": null, "slideHref": "/slides/019de071-1bdd-70bb-9c61-980d0c38b663/1", "deckHref": "/decks/019de071-1bdd-70bb-9c61-980d0c38b663", "deckAnchorHref": "/decks/019de071-1bdd-70bb-9c61-980d0c38b663#slide-1", "loopMatches": [], "arcBeatMatches": [ { "to": 3, "from": 1, "beatId": "2a803f0c-03c6-437c-92fc-be6008bde395", "arcName": "Monroe's Motivated Sequence", "arcSlug": "monroes-sequence", "beatName": "Attention", "beatSlug": "monroes-sequence-attention", "evidence": "The document starts with a cover slide and key messages to grab the audience's attention.", "position": 0, "confidence": 0.8, "parentBeatName": "Hook", "parentBeatSlug": "hook" } ], "imagePathAlt": "https://imgproxy.kitesheet.com/eWa_oHYCgDb3NSF-_EhHp5gOO-6oysCS7CK6t-0aLQ8/rs:fit:1200:1200:0/q:82/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy9hNDc5MmYxOGM1N2VhM2Y0YmEyN2U2OTZhNjM1MjBkZS9wMDAxLnBuZw", "thumbSrc": "https://imgproxy.kitesheet.com/l4krHJSNrqic0g-NxcpA_eZQfoZTNtgxpk8-MxThqYQ/rs:fit:480:480:0/q:78/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy9hNDc5MmYxOGM1N2VhM2Y0YmEyN2U2OTZhNjM1MjBkZS9wMDAxLmpwZw", "thumbSrcAlt": "https://imgproxy.kitesheet.com/W1UyRkTLIxdszBh4cXAmzg4f9yyerZJc0xbd1okOtsw/rs:fit:480:480:0/q:78/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy9hNDc5MmYxOGM1N2VhM2Y0YmEyN2U2OTZhNjM1MjBkZS9wMDAxLnBuZw" }, { "docId": "019de071-1bdd-70bb-9c61-980d0c38b663", "docSlug": "a4792f18c57ea3f4ba27e696a63520de", "documentTitle": "AstraZeneca | Investor Day Presentation Deck | 40 slides", "authorId": "astrazeneca", "authorName": "AstraZeneca", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2021-06-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.4148858, "pageNumber": 2, "slideType": "disclaimer", "function": "other", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de071-1bdd-70bb-9c61-980d0c38b663/2", "deckHref": "/decks/019de071-1bdd-70bb-9c61-980d0c38b663", "deckAnchorHref": "/decks/019de071-1bdd-70bb-9c61-980d0c38b663#slide-2", "loopMatches": [], "arcBeatMatches": [ { "to": 3, "from": 1, "beatId": "2a803f0c-03c6-437c-92fc-be6008bde395", "arcName": "Monroe's Motivated Sequence", "arcSlug": "monroes-sequence", "beatName": "Attention", "beatSlug": "monroes-sequence-attention", "evidence": "The document starts with a cover slide and key messages to grab the audience's attention.", "position": 0, "confidence": 0.8, "parentBeatName": "Hook", "parentBeatSlug": "hook" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de071-1bdd-70bb-9c61-980d0c38b663", "docSlug": "a4792f18c57ea3f4ba27e696a63520de", "documentTitle": "AstraZeneca | Investor Day Presentation Deck | 40 slides", "authorId": "astrazeneca", "authorName": "AstraZeneca", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2021-06-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.4148858, "pageNumber": 3, "slideType": "key_messages", "function": "summarize", "notes": "The slide uses a central image of a patient/medical team to humanize the strategic pillars.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de071-1bdd-70bb-9c61-980d0c38b663/3", "deckHref": "/decks/019de071-1bdd-70bb-9c61-980d0c38b663", "deckAnchorHref": "/decks/019de071-1bdd-70bb-9c61-980d0c38b663#slide-3", "loopMatches": [], "arcBeatMatches": [ { "to": 3, "from": 1, "beatId": "2a803f0c-03c6-437c-92fc-be6008bde395", "arcName": "Monroe's Motivated Sequence", "arcSlug": "monroes-sequence", "beatName": "Attention", "beatSlug": "monroes-sequence-attention", "evidence": "The document starts with a cover slide and key messages to grab the audience's attention.", "position": 0, "confidence": 0.8, "parentBeatName": "Hook", "parentBeatSlug": "hook" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de071-1bdd-70bb-9c61-980d0c38b663", "docSlug": "a4792f18c57ea3f4ba27e696a63520de", "documentTitle": "AstraZeneca | Investor Day Presentation Deck | 40 slides", "authorId": "astrazeneca", "authorName": "AstraZeneca", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2021-06-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.4148858, "pageNumber": 4, "slideType": "kpi_overview", "function": "summarize", "notes": "The slide uses a column-based layout to segment the portfolio by therapeutic area.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de071-1bdd-70bb-9c61-980d0c38b663/4", "deckHref": "/decks/019de071-1bdd-70bb-9c61-980d0c38b663", "deckAnchorHref": "/decks/019de071-1bdd-70bb-9c61-980d0c38b663#slide-4", "loopMatches": [ { "to": 10, "from": 4, "name": "Pattern Hunter", "slug": "02-pattern-hunter", "bestFor": "Time-pressed audiences, building consensus, when data is strong", "matchId": "cb0be392-a7b1-4037-8b53-e6e6f869695a", "evidence": "The document highlights several trends and patterns in oncology, including the importance of combinations and new Phase III medicines.", "position": 0, "objective": "What are the key trends and patterns in oncology?", "structure": "Evidence A -> Evidence B -> Evidence C -> Pattern/Conclusion", "confidence": 0.6, "description": "Group multiple pieces of evidence that together point to a pattern or conclusion" } ], "arcBeatMatches": [ { "to": 6, "from": 4, "beatId": "7159cdd6-69bd-490b-9adf-e3d02ec358ec", "arcName": "Monroe's Motivated Sequence", "arcSlug": "monroes-sequence", "beatName": "Need", "beatSlug": "monroes-sequence-need", "evidence": "The document highlights the need for innovation in oncology and AstraZeneca's position in the market.", "position": 1, "confidence": 0.8, "parentBeatName": "Complication", "parentBeatSlug": "complication" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de071-1bdd-70bb-9c61-980d0c38b663", "docSlug": "a4792f18c57ea3f4ba27e696a63520de", "documentTitle": "AstraZeneca | Investor Day Presentation Deck | 40 slides", "authorId": "astrazeneca", "authorName": "AstraZeneca", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2021-06-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.4148858, "pageNumber": 5, "slideType": "kpi_overview", "function": "analyze_data", "notes": "The slide uses a consistent color-coding for regions: US (dark blue), Europe (magenta), Established Rest of World (yellow), Emerging markets (green).", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de071-1bdd-70bb-9c61-980d0c38b663/5", "deckHref": "/decks/019de071-1bdd-70bb-9c61-980d0c38b663", "deckAnchorHref": "/decks/019de071-1bdd-70bb-9c61-980d0c38b663#slide-5", "loopMatches": [ { "to": 10, "from": 4, "name": "Pattern Hunter", "slug": "02-pattern-hunter", "bestFor": "Time-pressed audiences, building consensus, when data is strong", "matchId": "cb0be392-a7b1-4037-8b53-e6e6f869695a", "evidence": "The document highlights several trends and patterns in oncology, including the importance of combinations and new Phase III medicines.", "position": 0, "objective": "What are the key trends and patterns in oncology?", "structure": "Evidence A -> Evidence B -> Evidence C -> Pattern/Conclusion", "confidence": 0.6, "description": "Group multiple pieces of evidence that together point to a pattern or conclusion" } ], "arcBeatMatches": [ { "to": 6, "from": 4, "beatId": "7159cdd6-69bd-490b-9adf-e3d02ec358ec", "arcName": "Monroe's Motivated Sequence", "arcSlug": "monroes-sequence", "beatName": "Need", "beatSlug": "monroes-sequence-need", "evidence": "The document highlights the need for innovation in oncology and AstraZeneca's position in the market.", "position": 1, "confidence": 0.8, "parentBeatName": "Complication", "parentBeatSlug": "complication" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de071-1bdd-70bb-9c61-980d0c38b663", "docSlug": "a4792f18c57ea3f4ba27e696a63520de", "documentTitle": "AstraZeneca | Investor Day Presentation Deck | 40 slides", "authorId": "astrazeneca", "authorName": "AstraZeneca", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2021-06-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.4148858, "pageNumber": 6, "slideType": "key_takeaways", "function": "summarize", "notes": "The slide uses a circular timeline graphic to emphasize the 3rd consecutive plenary session achievement.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de071-1bdd-70bb-9c61-980d0c38b663/6", "deckHref": "/decks/019de071-1bdd-70bb-9c61-980d0c38b663", "deckAnchorHref": "/decks/019de071-1bdd-70bb-9c61-980d0c38b663#slide-6", "loopMatches": [ { "to": 10, "from": 4, "name": "Pattern Hunter", "slug": "02-pattern-hunter", "bestFor": "Time-pressed audiences, building consensus, when data is strong", "matchId": "cb0be392-a7b1-4037-8b53-e6e6f869695a", "evidence": "The document highlights several trends and patterns in oncology, including the importance of combinations and new Phase III medicines.", "position": 0, "objective": "What are the key trends and patterns in oncology?", "structure": "Evidence A -> Evidence B -> Evidence C -> Pattern/Conclusion", "confidence": 0.6, "description": "Group multiple pieces of evidence that together point to a pattern or conclusion" } ], "arcBeatMatches": [ { "to": 6, "from": 4, "beatId": "7159cdd6-69bd-490b-9adf-e3d02ec358ec", "arcName": "Monroe's Motivated Sequence", "arcSlug": "monroes-sequence", "beatName": "Need", "beatSlug": "monroes-sequence-need", "evidence": "The document highlights the need for innovation in oncology and AstraZeneca's position in the market.", "position": 1, "confidence": 0.8, "parentBeatName": "Complication", "parentBeatSlug": "complication" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de071-1bdd-70bb-9c61-980d0c38b663", "docSlug": "a4792f18c57ea3f4ba27e696a63520de", "documentTitle": "AstraZeneca | Investor Day Presentation Deck | 40 slides", "authorId": "astrazeneca", "authorName": "AstraZeneca", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2021-06-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.4148858, "pageNumber": 7, "slideType": "agenda", "function": "front_matter", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de071-1bdd-70bb-9c61-980d0c38b663/7", "deckHref": "/decks/019de071-1bdd-70bb-9c61-980d0c38b663", "deckAnchorHref": "/decks/019de071-1bdd-70bb-9c61-980d0c38b663#slide-7", "loopMatches": [ { "to": 10, "from": 4, "name": "Pattern Hunter", "slug": "02-pattern-hunter", "bestFor": "Time-pressed audiences, building consensus, when data is strong", "matchId": "cb0be392-a7b1-4037-8b53-e6e6f869695a", "evidence": "The document highlights several trends and patterns in oncology, including the importance of combinations and new Phase III medicines.", "position": 0, "objective": "What are the key trends and patterns in oncology?", "structure": "Evidence A -> Evidence B -> Evidence C -> Pattern/Conclusion", "confidence": 0.6, "description": "Group multiple pieces of evidence that together point to a pattern or conclusion" } ], "arcBeatMatches": [ { "to": 20, "from": 7, "beatId": "6407b6da-054c-43a3-924f-c8af0ea8759b", "arcName": "Monroe's Motivated Sequence", "arcSlug": "monroes-sequence", "beatName": "Satisfaction", "beatSlug": "monroes-sequence-satisfaction", "evidence": "The document showcases AstraZeneca's pipeline and progress in various areas of oncology, providing satisfaction to investors.", "position": 2, "confidence": 0.8, "parentBeatName": "Turn", "parentBeatSlug": "turn" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de071-1bdd-70bb-9c61-980d0c38b663", "docSlug": "a4792f18c57ea3f4ba27e696a63520de", "documentTitle": "AstraZeneca | Investor Day Presentation Deck | 40 slides", "authorId": "astrazeneca", "authorName": "AstraZeneca", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2021-06-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.4148858, "pageNumber": 8, "slideType": "cover", "function": "front_matter", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de071-1bdd-70bb-9c61-980d0c38b663/8", "deckHref": "/decks/019de071-1bdd-70bb-9c61-980d0c38b663", "deckAnchorHref": "/decks/019de071-1bdd-70bb-9c61-980d0c38b663#slide-8", "loopMatches": [ { "to": 10, "from": 4, "name": "Pattern Hunter", "slug": "02-pattern-hunter", "bestFor": "Time-pressed audiences, building consensus, when data is strong", "matchId": "cb0be392-a7b1-4037-8b53-e6e6f869695a", "evidence": "The document highlights several trends and patterns in oncology, including the importance of combinations and new Phase III medicines.", "position": 0, "objective": "What are the key trends and patterns in oncology?", "structure": "Evidence A -> Evidence B -> Evidence C -> Pattern/Conclusion", "confidence": 0.6, "description": "Group multiple pieces of evidence that together point to a pattern or conclusion" } ], "arcBeatMatches": [ { "to": 20, "from": 7, "beatId": "6407b6da-054c-43a3-924f-c8af0ea8759b", "arcName": "Monroe's Motivated Sequence", "arcSlug": "monroes-sequence", "beatName": "Satisfaction", "beatSlug": "monroes-sequence-satisfaction", "evidence": "The document showcases AstraZeneca's pipeline and progress in various areas of oncology, providing satisfaction to investors.", "position": 2, "confidence": 0.8, "parentBeatName": "Turn", "parentBeatSlug": "turn" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de071-1bdd-70bb-9c61-980d0c38b663", "docSlug": "a4792f18c57ea3f4ba27e696a63520de", "documentTitle": "AstraZeneca | Investor Day Presentation Deck | 40 slides", "authorId": "astrazeneca", "authorName": "AstraZeneca", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2021-06-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.4148858, "pageNumber": 9, "slideType": "key_messages", "function": "summarize", "notes": "The slide uses a three-pillar framework to organize the strategic approach to lung cancer care.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de071-1bdd-70bb-9c61-980d0c38b663/9", "deckHref": "/decks/019de071-1bdd-70bb-9c61-980d0c38b663", "deckAnchorHref": "/decks/019de071-1bdd-70bb-9c61-980d0c38b663#slide-9", "loopMatches": [ { "to": 10, "from": 4, "name": "Pattern Hunter", "slug": "02-pattern-hunter", "bestFor": "Time-pressed audiences, building consensus, when data is strong", "matchId": "cb0be392-a7b1-4037-8b53-e6e6f869695a", "evidence": "The document highlights several trends and patterns in oncology, including the importance of combinations and new Phase III medicines.", "position": 0, "objective": "What are the key trends and patterns in oncology?", "structure": "Evidence A -> Evidence B -> Evidence C -> Pattern/Conclusion", "confidence": 0.6, "description": "Group multiple pieces of evidence that together point to a pattern or conclusion" } ], "arcBeatMatches": [ { "to": 20, "from": 7, "beatId": "6407b6da-054c-43a3-924f-c8af0ea8759b", "arcName": "Monroe's Motivated Sequence", "arcSlug": "monroes-sequence", "beatName": "Satisfaction", "beatSlug": "monroes-sequence-satisfaction", "evidence": "The document showcases AstraZeneca's pipeline and progress in various areas of oncology, providing satisfaction to investors.", "position": 2, "confidence": 0.8, "parentBeatName": "Turn", "parentBeatSlug": "turn" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de071-1bdd-70bb-9c61-980d0c38b663", "docSlug": "a4792f18c57ea3f4ba27e696a63520de", "documentTitle": "AstraZeneca | Investor Day Presentation Deck | 40 slides", "authorId": "astrazeneca", "authorName": "AstraZeneca", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2021-06-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.4148858, "pageNumber": 10, "slideType": "key_takeaways", "function": "summarize", "notes": "Includes a Kaplan-Meier survival curve and a bar chart showing patient reach growth.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de071-1bdd-70bb-9c61-980d0c38b663/10", "deckHref": "/decks/019de071-1bdd-70bb-9c61-980d0c38b663", "deckAnchorHref": "/decks/019de071-1bdd-70bb-9c61-980d0c38b663#slide-10", "loopMatches": [ { "to": 10, "from": 4, "name": "Pattern Hunter", "slug": "02-pattern-hunter", "bestFor": "Time-pressed audiences, building consensus, when data is strong", "matchId": "cb0be392-a7b1-4037-8b53-e6e6f869695a", "evidence": "The document highlights several trends and patterns in oncology, including the importance of combinations and new Phase III medicines.", "position": 0, "objective": "What are the key trends and patterns in oncology?", "structure": "Evidence A -> Evidence B -> Evidence C -> Pattern/Conclusion", "confidence": 0.6, "description": "Group multiple pieces of evidence that together point to a pattern or conclusion" } ], "arcBeatMatches": [ { "to": 20, "from": 7, "beatId": "6407b6da-054c-43a3-924f-c8af0ea8759b", "arcName": "Monroe's Motivated Sequence", "arcSlug": "monroes-sequence", "beatName": "Satisfaction", "beatSlug": "monroes-sequence-satisfaction", "evidence": "The document showcases AstraZeneca's pipeline and progress in various areas of oncology, providing satisfaction to investors.", "position": 2, "confidence": 0.8, "parentBeatName": "Turn", "parentBeatSlug": "turn" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de071-1bdd-70bb-9c61-980d0c38b663", "docSlug": "a4792f18c57ea3f4ba27e696a63520de", "documentTitle": "AstraZeneca | Investor Day Presentation Deck | 40 slides", "authorId": "astrazeneca", "authorName": "AstraZeneca", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2021-06-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.4148858, "pageNumber": 11, "slideType": "roadmap", "function": "plan_implementation", "notes": "The slide uses a color-coded legend to distinguish between approved indications and ongoing trials across the disease continuum.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de071-1bdd-70bb-9c61-980d0c38b663/11", "deckHref": "/decks/019de071-1bdd-70bb-9c61-980d0c38b663", "deckAnchorHref": "/decks/019de071-1bdd-70bb-9c61-980d0c38b663#slide-11", "loopMatches": [], "arcBeatMatches": [ { "to": 20, "from": 7, "beatId": "6407b6da-054c-43a3-924f-c8af0ea8759b", "arcName": "Monroe's Motivated Sequence", "arcSlug": "monroes-sequence", "beatName": "Satisfaction", "beatSlug": "monroes-sequence-satisfaction", "evidence": "The document showcases AstraZeneca's pipeline and progress in various areas of oncology, providing satisfaction to investors.", "position": 2, "confidence": 0.8, "parentBeatName": "Turn", "parentBeatSlug": "turn" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de071-1bdd-70bb-9c61-980d0c38b663", "docSlug": "a4792f18c57ea3f4ba27e696a63520de", "documentTitle": "AstraZeneca | Investor Day Presentation Deck | 40 slides", "authorId": "astrazeneca", "authorName": "AstraZeneca", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2021-06-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.4148858, "pageNumber": 12, "slideType": "comparison_table", "function": "analyze_data", "notes": "Slide presents two distinct drug portfolios with corresponding clinical trial results (DESTINY-Lung01 and TROPION-PanTumor01).", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de071-1bdd-70bb-9c61-980d0c38b663/12", "deckHref": "/decks/019de071-1bdd-70bb-9c61-980d0c38b663", "deckAnchorHref": "/decks/019de071-1bdd-70bb-9c61-980d0c38b663#slide-12", "loopMatches": [], "arcBeatMatches": [ { "to": 20, "from": 7, "beatId": "6407b6da-054c-43a3-924f-c8af0ea8759b", "arcName": "Monroe's Motivated Sequence", "arcSlug": "monroes-sequence", "beatName": "Satisfaction", "beatSlug": "monroes-sequence-satisfaction", "evidence": "The document showcases AstraZeneca's pipeline and progress in various areas of oncology, providing satisfaction to investors.", "position": 2, "confidence": 0.8, "parentBeatName": "Turn", "parentBeatSlug": "turn" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de071-1bdd-70bb-9c61-980d0c38b663", "docSlug": "a4792f18c57ea3f4ba27e696a63520de", "documentTitle": "AstraZeneca | Investor Day Presentation Deck | 40 slides", "authorId": "astrazeneca", "authorName": "AstraZeneca", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2021-06-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.4148858, "pageNumber": 13, "slideType": "key_messages", "function": "analyze_data", "notes": "The slide uses Kaplan-Meier survival curves to demonstrate clinical efficacy.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de071-1bdd-70bb-9c61-980d0c38b663/13", "deckHref": "/decks/019de071-1bdd-70bb-9c61-980d0c38b663", "deckAnchorHref": "/decks/019de071-1bdd-70bb-9c61-980d0c38b663#slide-13", "loopMatches": [], "arcBeatMatches": [ { "to": 20, "from": 7, "beatId": "6407b6da-054c-43a3-924f-c8af0ea8759b", "arcName": "Monroe's Motivated Sequence", "arcSlug": "monroes-sequence", "beatName": "Satisfaction", "beatSlug": "monroes-sequence-satisfaction", "evidence": "The document showcases AstraZeneca's pipeline and progress in various areas of oncology, providing satisfaction to investors.", "position": 2, "confidence": 0.8, "parentBeatName": "Turn", "parentBeatSlug": "turn" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de071-1bdd-70bb-9c61-980d0c38b663", "docSlug": "a4792f18c57ea3f4ba27e696a63520de", "documentTitle": "AstraZeneca | Investor Day Presentation Deck | 40 slides", "authorId": "astrazeneca", "authorName": "AstraZeneca", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2021-06-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.4148858, "pageNumber": 14, "slideType": "roadmap", "function": "present_solution", "notes": "The slide uses a horizontal bar chart format to map drug indications against disease progression stages.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de071-1bdd-70bb-9c61-980d0c38b663/14", "deckHref": "/decks/019de071-1bdd-70bb-9c61-980d0c38b663", "deckAnchorHref": "/decks/019de071-1bdd-70bb-9c61-980d0c38b663#slide-14", "loopMatches": [], "arcBeatMatches": [ { "to": 20, "from": 7, "beatId": "6407b6da-054c-43a3-924f-c8af0ea8759b", "arcName": "Monroe's Motivated Sequence", "arcSlug": "monroes-sequence", "beatName": "Satisfaction", "beatSlug": "monroes-sequence-satisfaction", "evidence": "The document showcases AstraZeneca's pipeline and progress in various areas of oncology, providing satisfaction to investors.", "position": 2, "confidence": 0.8, "parentBeatName": "Turn", "parentBeatSlug": "turn" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de071-1bdd-70bb-9c61-980d0c38b663", "docSlug": "a4792f18c57ea3f4ba27e696a63520de", "documentTitle": "AstraZeneca | Investor Day Presentation Deck | 40 slides", "authorId": "astrazeneca", "authorName": "AstraZeneca", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2021-06-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.4148858, "pageNumber": 15, "slideType": "cover", "function": "front_matter", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de071-1bdd-70bb-9c61-980d0c38b663/15", "deckHref": "/decks/019de071-1bdd-70bb-9c61-980d0c38b663", "deckAnchorHref": "/decks/019de071-1bdd-70bb-9c61-980d0c38b663#slide-15", "loopMatches": [], "arcBeatMatches": [ { "to": 20, "from": 7, "beatId": "6407b6da-054c-43a3-924f-c8af0ea8759b", "arcName": "Monroe's Motivated Sequence", "arcSlug": "monroes-sequence", "beatName": "Satisfaction", "beatSlug": "monroes-sequence-satisfaction", "evidence": "The document showcases AstraZeneca's pipeline and progress in various areas of oncology, providing satisfaction to investors.", "position": 2, "confidence": 0.8, "parentBeatName": "Turn", "parentBeatSlug": "turn" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de071-1bdd-70bb-9c61-980d0c38b663", "docSlug": "a4792f18c57ea3f4ba27e696a63520de", "documentTitle": "AstraZeneca | Investor Day Presentation Deck | 40 slides", "authorId": "astrazeneca", "authorName": "AstraZeneca", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2021-06-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.4148858, "pageNumber": 16, "slideType": "timeline", "function": "establish_context", "notes": "The slide uses a timeline structure to demonstrate long-term innovation and market presence.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de071-1bdd-70bb-9c61-980d0c38b663/16", "deckHref": "/decks/019de071-1bdd-70bb-9c61-980d0c38b663", "deckAnchorHref": "/decks/019de071-1bdd-70bb-9c61-980d0c38b663#slide-16", "loopMatches": [], "arcBeatMatches": [ { "to": 20, "from": 7, "beatId": "6407b6da-054c-43a3-924f-c8af0ea8759b", "arcName": "Monroe's Motivated Sequence", "arcSlug": "monroes-sequence", "beatName": "Satisfaction", "beatSlug": "monroes-sequence-satisfaction", "evidence": "The document showcases AstraZeneca's pipeline and progress in various areas of oncology, providing satisfaction to investors.", "position": 2, "confidence": 0.8, "parentBeatName": "Turn", "parentBeatSlug": "turn" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de071-1bdd-70bb-9c61-980d0c38b663", "docSlug": "a4792f18c57ea3f4ba27e696a63520de", "documentTitle": "AstraZeneca | Investor Day Presentation Deck | 40 slides", "authorId": "astrazeneca", "authorName": "AstraZeneca", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2021-06-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.4148858, "pageNumber": 17, "slideType": "key_messages", "function": "present_framework", "notes": "The slide uses a three-column layout to define strategic pillars, each supported by specific tactical focus areas represented by circular icons.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de071-1bdd-70bb-9c61-980d0c38b663/17", "deckHref": "/decks/019de071-1bdd-70bb-9c61-980d0c38b663", "deckAnchorHref": "/decks/019de071-1bdd-70bb-9c61-980d0c38b663#slide-17", "loopMatches": [], "arcBeatMatches": [ { "to": 20, "from": 7, "beatId": "6407b6da-054c-43a3-924f-c8af0ea8759b", "arcName": "Monroe's Motivated Sequence", "arcSlug": "monroes-sequence", "beatName": "Satisfaction", "beatSlug": "monroes-sequence-satisfaction", "evidence": "The document showcases AstraZeneca's pipeline and progress in various areas of oncology, providing satisfaction to investors.", "position": 2, "confidence": 0.8, "parentBeatName": "Turn", "parentBeatSlug": "turn" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de071-1bdd-70bb-9c61-980d0c38b663", "docSlug": "a4792f18c57ea3f4ba27e696a63520de", "documentTitle": "AstraZeneca | Investor Day Presentation Deck | 40 slides", "authorId": "astrazeneca", "authorName": "AstraZeneca", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2021-06-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.4148858, "pageNumber": 18, "slideType": "thesis_headline", "function": "analyze_data", "notes": "The slide uses a Kaplan-Meier curve to demonstrate clinical efficacy, supported by epidemiological data on the right.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de071-1bdd-70bb-9c61-980d0c38b663/18", "deckHref": "/decks/019de071-1bdd-70bb-9c61-980d0c38b663", "deckAnchorHref": "/decks/019de071-1bdd-70bb-9c61-980d0c38b663#slide-18", "loopMatches": [], "arcBeatMatches": [ { "to": 20, "from": 7, "beatId": "6407b6da-054c-43a3-924f-c8af0ea8759b", "arcName": "Monroe's Motivated Sequence", "arcSlug": "monroes-sequence", "beatName": "Satisfaction", "beatSlug": "monroes-sequence-satisfaction", "evidence": "The document showcases AstraZeneca's pipeline and progress in various areas of oncology, providing satisfaction to investors.", "position": 2, "confidence": 0.8, "parentBeatName": "Turn", "parentBeatSlug": "turn" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de071-1bdd-70bb-9c61-980d0c38b663", "docSlug": "a4792f18c57ea3f4ba27e696a63520de", "documentTitle": "AstraZeneca | Investor Day Presentation Deck | 40 slides", "authorId": "astrazeneca", "authorName": "AstraZeneca", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2021-06-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.4148858, "pageNumber": 19, "slideType": "key_takeaways", "function": "summarize", "notes": "Includes a waterfall chart showing clinical response data and a list of upcoming trial milestones.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de071-1bdd-70bb-9c61-980d0c38b663/19", "deckHref": "/decks/019de071-1bdd-70bb-9c61-980d0c38b663", "deckAnchorHref": "/decks/019de071-1bdd-70bb-9c61-980d0c38b663#slide-19", "loopMatches": [], "arcBeatMatches": [ { "to": 20, "from": 7, "beatId": "6407b6da-054c-43a3-924f-c8af0ea8759b", "arcName": "Monroe's Motivated Sequence", "arcSlug": "monroes-sequence", "beatName": "Satisfaction", "beatSlug": "monroes-sequence-satisfaction", "evidence": "The document showcases AstraZeneca's pipeline and progress in various areas of oncology, providing satisfaction to investors.", "position": 2, "confidence": 0.8, "parentBeatName": "Turn", "parentBeatSlug": "turn" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de071-1bdd-70bb-9c61-980d0c38b663", "docSlug": "a4792f18c57ea3f4ba27e696a63520de", "documentTitle": "AstraZeneca | Investor Day Presentation Deck | 40 slides", "authorId": "astrazeneca", "authorName": "AstraZeneca", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2021-06-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.4148858, "pageNumber": 20, "slideType": "roadmap", "function": "plan_implementation", "notes": "The slide uses a matrix-like layout to map clinical trial phases and treatment strategies against patient segments.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de071-1bdd-70bb-9c61-980d0c38b663/20", "deckHref": "/decks/019de071-1bdd-70bb-9c61-980d0c38b663", "deckAnchorHref": "/decks/019de071-1bdd-70bb-9c61-980d0c38b663#slide-20", "loopMatches": [], "arcBeatMatches": [ { "to": 20, "from": 7, "beatId": "6407b6da-054c-43a3-924f-c8af0ea8759b", "arcName": "Monroe's Motivated Sequence", "arcSlug": "monroes-sequence", "beatName": "Satisfaction", "beatSlug": "monroes-sequence-satisfaction", "evidence": "The document showcases AstraZeneca's pipeline and progress in various areas of oncology, providing satisfaction to investors.", "position": 2, "confidence": 0.8, "parentBeatName": "Turn", "parentBeatSlug": "turn" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de071-1bdd-70bb-9c61-980d0c38b663", "docSlug": "a4792f18c57ea3f4ba27e696a63520de", "documentTitle": "AstraZeneca | Investor Day Presentation Deck | 40 slides", "authorId": "astrazeneca", "authorName": "AstraZeneca", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2021-06-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.4148858, "pageNumber": 21, "slideType": "competitive_analysis", "function": "compare_peers", "notes": "The slide uses a three-column layout to compare different drug assets in the pipeline.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de071-1bdd-70bb-9c61-980d0c38b663/21", "deckHref": "/decks/019de071-1bdd-70bb-9c61-980d0c38b663", "deckAnchorHref": "/decks/019de071-1bdd-70bb-9c61-980d0c38b663#slide-21", "loopMatches": [ { "to": 28, "from": 21, "name": "Cost Of Inaction", "slug": "27-cost-of-inaction", "bestFor": "Urgent budget requests, compliance, risk mitigation", "matchId": "cde01b8e-53ce-45e4-b3c4-d519c08ca374", "evidence": "The document implies that not investing in oncology would result in missed opportunities for growth and patient benefit.", "position": 1, "objective": "What are the consequences of not investing in oncology?", "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point", "confidence": 0.6, "description": "Quantify what happens if the audience does nothing" } ], "arcBeatMatches": [ { "to": 40, "from": 21, "beatId": "9bb24be0-c8c7-49aa-a526-e9fcc4794b51", "arcName": "Monroe's Motivated Sequence", "arcSlug": "monroes-sequence", "beatName": "Action", "beatSlug": "monroes-sequence-action", "evidence": "The document concludes with a call to action and next steps for investors.", "position": 3, "confidence": 0.8, "parentBeatName": "Resolution", "parentBeatSlug": "resolution" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de071-1bdd-70bb-9c61-980d0c38b663", "docSlug": "a4792f18c57ea3f4ba27e696a63520de", "documentTitle": "AstraZeneca | Investor Day Presentation Deck | 40 slides", "authorId": "astrazeneca", "authorName": "AstraZeneca", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2021-06-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.4148858, "pageNumber": 22, "slideType": "comparison_table", "function": "present_solution", "notes": "The slide uses a grid layout to map drug indications against patient segments and treatment lines.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de071-1bdd-70bb-9c61-980d0c38b663/22", "deckHref": "/decks/019de071-1bdd-70bb-9c61-980d0c38b663", "deckAnchorHref": "/decks/019de071-1bdd-70bb-9c61-980d0c38b663#slide-22", "loopMatches": [ { "to": 28, "from": 21, "name": "Cost Of Inaction", "slug": "27-cost-of-inaction", "bestFor": "Urgent budget requests, compliance, risk mitigation", "matchId": "cde01b8e-53ce-45e4-b3c4-d519c08ca374", "evidence": "The document implies that not investing in oncology would result in missed opportunities for growth and patient benefit.", "position": 1, "objective": "What are the consequences of not investing in oncology?", "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point", "confidence": 0.6, "description": "Quantify what happens if the audience does nothing" } ], "arcBeatMatches": [ { "to": 40, "from": 21, "beatId": "9bb24be0-c8c7-49aa-a526-e9fcc4794b51", "arcName": "Monroe's Motivated Sequence", "arcSlug": "monroes-sequence", "beatName": "Action", "beatSlug": "monroes-sequence-action", "evidence": "The document concludes with a call to action and next steps for investors.", "position": 3, "confidence": 0.8, "parentBeatName": "Resolution", "parentBeatSlug": "resolution" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de071-1bdd-70bb-9c61-980d0c38b663", "docSlug": "a4792f18c57ea3f4ba27e696a63520de", "documentTitle": "AstraZeneca | Investor Day Presentation Deck | 40 slides", "authorId": "astrazeneca", "authorName": "AstraZeneca", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2021-06-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.4148858, "pageNumber": 23, "slideType": "cover", "function": "front_matter", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de071-1bdd-70bb-9c61-980d0c38b663/23", "deckHref": "/decks/019de071-1bdd-70bb-9c61-980d0c38b663", "deckAnchorHref": "/decks/019de071-1bdd-70bb-9c61-980d0c38b663#slide-23", "loopMatches": [ { "to": 28, "from": 21, "name": "Cost Of Inaction", "slug": "27-cost-of-inaction", "bestFor": "Urgent budget requests, compliance, risk mitigation", "matchId": "cde01b8e-53ce-45e4-b3c4-d519c08ca374", "evidence": "The document implies that not investing in oncology would result in missed opportunities for growth and patient benefit.", "position": 1, "objective": "What are the consequences of not investing in oncology?", "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point", "confidence": 0.6, "description": "Quantify what happens if the audience does nothing" } ], "arcBeatMatches": [ { "to": 40, "from": 21, "beatId": "9bb24be0-c8c7-49aa-a526-e9fcc4794b51", "arcName": "Monroe's Motivated Sequence", "arcSlug": "monroes-sequence", "beatName": "Action", "beatSlug": "monroes-sequence-action", "evidence": "The document concludes with a call to action and next steps for investors.", "position": 3, "confidence": 0.8, "parentBeatName": "Resolution", "parentBeatSlug": "resolution" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de071-1bdd-70bb-9c61-980d0c38b663", "docSlug": "a4792f18c57ea3f4ba27e696a63520de", "documentTitle": "AstraZeneca | Investor Day Presentation Deck | 40 slides", "authorId": "astrazeneca", "authorName": "AstraZeneca", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2021-06-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.4148858, "pageNumber": 24, "slideType": "before_after", "function": "analyze_data", "notes": "The slide uses Kaplan-Meier survival curves to demonstrate efficacy in two distinct clinical settings.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de071-1bdd-70bb-9c61-980d0c38b663/24", "deckHref": "/decks/019de071-1bdd-70bb-9c61-980d0c38b663", "deckAnchorHref": "/decks/019de071-1bdd-70bb-9c61-980d0c38b663#slide-24", "loopMatches": [ { "to": 28, "from": 21, "name": "Cost Of Inaction", "slug": "27-cost-of-inaction", "bestFor": "Urgent budget requests, compliance, risk mitigation", "matchId": "cde01b8e-53ce-45e4-b3c4-d519c08ca374", "evidence": "The document implies that not investing in oncology would result in missed opportunities for growth and patient benefit.", "position": 1, "objective": "What are the consequences of not investing in oncology?", "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point", "confidence": 0.6, "description": "Quantify what happens if the audience does nothing" } ], "arcBeatMatches": [ { "to": 40, "from": 21, "beatId": "9bb24be0-c8c7-49aa-a526-e9fcc4794b51", "arcName": "Monroe's Motivated Sequence", "arcSlug": "monroes-sequence", "beatName": "Action", "beatSlug": "monroes-sequence-action", "evidence": "The document concludes with a call to action and next steps for investors.", "position": 3, "confidence": 0.8, "parentBeatName": "Resolution", "parentBeatSlug": "resolution" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de071-1bdd-70bb-9c61-980d0c38b663", "docSlug": "a4792f18c57ea3f4ba27e696a63520de", "documentTitle": "AstraZeneca | Investor Day Presentation Deck | 40 slides", "authorId": "astrazeneca", "authorName": "AstraZeneca", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2021-06-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.4148858, "pageNumber": 25, "slideType": "key_takeaways", "function": "analyze_data", "notes": "The slide uses a stacked bar chart to show revenue growth over time, segmented by region, alongside key performance indicators for US and Ex-US markets.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de071-1bdd-70bb-9c61-980d0c38b663/25", "deckHref": "/decks/019de071-1bdd-70bb-9c61-980d0c38b663", "deckAnchorHref": "/decks/019de071-1bdd-70bb-9c61-980d0c38b663#slide-25", "loopMatches": [ { "to": 28, "from": 21, "name": "Cost Of Inaction", "slug": "27-cost-of-inaction", "bestFor": "Urgent budget requests, compliance, risk mitigation", "matchId": "cde01b8e-53ce-45e4-b3c4-d519c08ca374", "evidence": "The document implies that not investing in oncology would result in missed opportunities for growth and patient benefit.", "position": 1, "objective": "What are the consequences of not investing in oncology?", "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point", "confidence": 0.6, "description": "Quantify what happens if the audience does nothing" } ], "arcBeatMatches": [ { "to": 40, "from": 21, "beatId": "9bb24be0-c8c7-49aa-a526-e9fcc4794b51", "arcName": "Monroe's Motivated Sequence", "arcSlug": "monroes-sequence", "beatName": "Action", "beatSlug": "monroes-sequence-action", "evidence": "The document concludes with a call to action and next steps for investors.", "position": 3, "confidence": 0.8, "parentBeatName": "Resolution", "parentBeatSlug": "resolution" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de071-1bdd-70bb-9c61-980d0c38b663", "docSlug": "a4792f18c57ea3f4ba27e696a63520de", "documentTitle": "AstraZeneca | Investor Day Presentation Deck | 40 slides", "authorId": "astrazeneca", "authorName": "AstraZeneca", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2021-06-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.4148858, "pageNumber": 26, "slideType": "geographic_map", "function": "plan_implementation", "notes": "The slide uses color-coding on the map to represent the three waves of the global rollout.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de071-1bdd-70bb-9c61-980d0c38b663/26", "deckHref": "/decks/019de071-1bdd-70bb-9c61-980d0c38b663", "deckAnchorHref": "/decks/019de071-1bdd-70bb-9c61-980d0c38b663#slide-26", "loopMatches": [ { "to": 28, "from": 21, "name": "Cost Of Inaction", "slug": "27-cost-of-inaction", "bestFor": "Urgent budget requests, compliance, risk mitigation", "matchId": "cde01b8e-53ce-45e4-b3c4-d519c08ca374", "evidence": "The document implies that not investing in oncology would result in missed opportunities for growth and patient benefit.", "position": 1, "objective": "What are the consequences of not investing in oncology?", "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point", "confidence": 0.6, "description": "Quantify what happens if the audience does nothing" } ], "arcBeatMatches": [ { "to": 40, "from": 21, "beatId": "9bb24be0-c8c7-49aa-a526-e9fcc4794b51", "arcName": "Monroe's Motivated Sequence", "arcSlug": "monroes-sequence", "beatName": "Action", "beatSlug": "monroes-sequence-action", "evidence": "The document concludes with a call to action and next steps for investors.", "position": 3, "confidence": 0.8, "parentBeatName": "Resolution", "parentBeatSlug": "resolution" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de071-1bdd-70bb-9c61-980d0c38b663", "docSlug": "a4792f18c57ea3f4ba27e696a63520de", "documentTitle": "AstraZeneca | Investor Day Presentation Deck | 40 slides", "authorId": "astrazeneca", "authorName": "AstraZeneca", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2021-06-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.4148858, "pageNumber": 27, "slideType": "key_takeaways", "function": "analyze_data", "notes": "Data from ELEVATE-TN Phase III trial presented at ASCO 2021.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de071-1bdd-70bb-9c61-980d0c38b663/27", "deckHref": "/decks/019de071-1bdd-70bb-9c61-980d0c38b663", "deckAnchorHref": "/decks/019de071-1bdd-70bb-9c61-980d0c38b663#slide-27", "loopMatches": [ { "to": 28, "from": 21, "name": "Cost Of Inaction", "slug": "27-cost-of-inaction", "bestFor": "Urgent budget requests, compliance, risk mitigation", "matchId": "cde01b8e-53ce-45e4-b3c4-d519c08ca374", "evidence": "The document implies that not investing in oncology would result in missed opportunities for growth and patient benefit.", "position": 1, "objective": "What are the consequences of not investing in oncology?", "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point", "confidence": 0.6, "description": "Quantify what happens if the audience does nothing" } ], "arcBeatMatches": [ { "to": 40, "from": 21, "beatId": "9bb24be0-c8c7-49aa-a526-e9fcc4794b51", "arcName": "Monroe's Motivated Sequence", "arcSlug": "monroes-sequence", "beatName": "Action", "beatSlug": "monroes-sequence-action", "evidence": "The document concludes with a call to action and next steps for investors.", "position": 3, "confidence": 0.8, "parentBeatName": "Resolution", "parentBeatSlug": "resolution" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de071-1bdd-70bb-9c61-980d0c38b663", "docSlug": "a4792f18c57ea3f4ba27e696a63520de", "documentTitle": "AstraZeneca | Investor Day Presentation Deck | 40 slides", "authorId": "astrazeneca", "authorName": "AstraZeneca", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2021-06-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.4148858, "pageNumber": 28, "slideType": "comparison_table", "function": "analyze_data", "notes": "Source: abstract 7500, ASCO 2021.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de071-1bdd-70bb-9c61-980d0c38b663/28", "deckHref": "/decks/019de071-1bdd-70bb-9c61-980d0c38b663", "deckAnchorHref": "/decks/019de071-1bdd-70bb-9c61-980d0c38b663#slide-28", "loopMatches": [ { "to": 28, "from": 21, "name": "Cost Of Inaction", "slug": "27-cost-of-inaction", "bestFor": "Urgent budget requests, compliance, risk mitigation", "matchId": "cde01b8e-53ce-45e4-b3c4-d519c08ca374", "evidence": "The document implies that not investing in oncology would result in missed opportunities for growth and patient benefit.", "position": 1, "objective": "What are the consequences of not investing in oncology?", "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point", "confidence": 0.6, "description": "Quantify what happens if the audience does nothing" } ], "arcBeatMatches": [ { "to": 40, "from": 21, "beatId": "9bb24be0-c8c7-49aa-a526-e9fcc4794b51", "arcName": "Monroe's Motivated Sequence", "arcSlug": "monroes-sequence", "beatName": "Action", "beatSlug": "monroes-sequence-action", "evidence": "The document concludes with a call to action and next steps for investors.", "position": 3, "confidence": 0.8, "parentBeatName": "Resolution", "parentBeatSlug": "resolution" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true } ] }